David Pauck

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

Viktoria Marquardt, Johanna Theruvath, David Pauck et al. · Journal for ImmunoTherapy of Cancer · 2023 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

Ulvi Ahmadov, Daniel Picard, Jasmin Bartl et al. · Cell Death and Disease · 2021 · 54 citations · Full text

Life Sciences, Genetics, Oncology +17

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing

Florian Selt, Juliane Hohloch, Thomas Hielscher et al. · Oncotarget · 2016 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

Donata Maciaczyk, Daniel Picard, Lili Zhao et al. · British Journal of Cancer · 2017 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +17

The long noncoding RNA <i>TP73‐AS1</i> promotes tumorigenicity of medulloblastoma cells

Mor Varon, Tal Levy, Gal Mazor et al. · International Journal of Cancer · 2019 · 36 citations

Life Sciences, Molecular Biology, Oncology +17